Utama › Kanser Ginjal › California

Kajian klinikal Kanser Ginjal di California

19 kajian untuk Kanser Ginjal sedang mencari peserta di lokasi di California.

Bandar di California

Teks kajian rasmi (Bahasa Inggeris)

Distance-Based Exercise to Preserve Function and Prevent Disability

Kaiser Permanente Dublin, Dublin
Kaiser Permanente-Fremont, Fremont
Kaiser Permanente Fresno Orchard Plaza, Fresno
dan 10 lagi

Mengambil peserta

Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07059884

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

University of California San Diego Moores Cancer Center, La Jolla
Cedars-Sinai Medical Center, Los Angeles

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06234605

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

University of California Irvine, Orange
Stanford, Palo Alto
University of California San Francisco, San Francisco

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05287945

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

Research Site, Duarte
Research Site, Irvine
Research Site, La Jolla
dan 4 lagi

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07011719

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

University of California San Diego, La Jolla
Stanford University, Palo Alto
UCLA Medical Center, Santa Monica

Mengambil pesertaKajian pemerhatian

Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT04981119

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
City of Hope Investigational Drug Services (IDS), Duarte
UC San Diego Medical Center - Encinitas, Encinitas
dan 13 lagi

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07227415

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

Research Site, San Diego
Research Site, Santa Monica

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 31 Ogo 2026 · NCT05536141

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

NEO-811 Los Angeles Site, Duarte
NEO-811 San Diego Site, San Diego

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT07300241

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Xencor Investigative Site, Duarte
Xencor Investigative Site, Sacramento

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT05433142

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Chao Family Comprehensive Cancer Center, University of California Irvine, Orange

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 14 Jul 2026 · NCT06580002

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

University of Southern California, Los Angeles
Cedars-Sinai Medical Center, Los Angeles
UCLA Department of Medicine, Los Angeles

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 8 Jun 2026 · NCT06026410

A Study of VET3-TGI in Patients With Solid Tumors

USC/Norris Comprehensive Cancer Center, Los Angeles
UC Irvine Health, Orange

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 7 Apr 2026 · NCT06444815

64Cu-GRIP B in Patients With Advanced Malignancies

University of California, San Francisco, San Francisco

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 17 Mac 2026 · NCT05888532

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

City of Hope, Duarte

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan

Umur 40 ke atas · Semua jantina · Dikemas kini 20 Jan 2026 · NCT05366881

Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology

VA Palo Alto Healthcare System, Palo Alto

Mengambil pesertaKajian pemerhatian

Umur 18 ke atas · Semua jantina · Dikemas kini 26 Dis 2025 · NCT07303725

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Duarte
Massive Bio SYNERGY-AI site, Irvine
Massive Bio SYNERGY-AI site, La Jolla
dan 3 lagi

Mengambil pesertaKajian pemerhatian

Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

UCSD Moores Cancer Center, La Jolla
UCLA Medical Center, Los Angeles

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2025 · NCT06682793

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 27 Jun 2025 · NCT03175224

International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors

Institute of Urology, University of Southern California., Los Angeles
University of California San Diego, Moores Cancer Center, San Diego
Stanford University, Stanford

Mengambil pesertaKajian pemerhatian

Umur 18 ke atas · Semua jantina · Dikemas kini 6 Mei 2022 · NCT05363657

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.